Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr...

Area of Science:

• Ophthalmology
• Nanomedicine
• Neuroscience

Background:

• Oxidative stress from excess reactive oxygen species (ROS) contributes to neurodegenerative diseases like age-related macular degeneration (AMD) and diabetic retinopathy (DR).
• The Vldlr knockout mouse model exhibits intraretinal and subretinal neovascular lesions, serving as a model for retinal angiomatous proliferation (RAP), a form of AMD.

Purpose of the Study:

• To investigate the therapeutic potential of cerium oxide nanoparticles (nanoceria) in mitigating oxidative stress and neovascularization in the Vldlr knockout mouse model.
• To determine if nanoceria can both prevent and reverse pathological neovascular lesions in the retina.

Main Methods:

• Intravitreal injection of nanoceria into Vldlr knockout mice.
• Measurement of reactive oxygen species (ROS) levels and vascular endothelial growth factor (VEGF) in retinal tissues.
• Assessment of intraretinal and subretinal neovascular lesion formation and regression.

Main Results:

• Nanoceria injection inhibited the rise in ROS and VEGF in the Vldlr knockout retina.
• Nanoceria prevented the formation of new intraretinal and subretinal neovascular lesions.
• Injection of nanoceria into older mice led to the regression of existing vascular lesions.

Conclusions:

• Cerium oxide nanoparticles effectively scavenge ROS and inhibit neovascularization in a mouse model of AMD.
• Nanoceria demonstrate both preventative and therapeutic potential for treating blinding retinal diseases driven by oxidative stress.
• These findings support the use of nanoceria as a therapeutic agent for neurodegenerative retinal conditions like AMD and DR.